In response to targeted imaging modality selection for bacterial biofilms in chronic rhinosinusitis and different biofilms, different disease? A clinical outcomes study

Simple item page
dc.contributor.authorForeman, A.
dc.contributor.authorWormald, P.J.
dc.date.issued2011
dc.descriptionLetter to the editor
dc.description.statementofresponsibilityAndrew Foreman and Peter-John Wormald
dc.identifier.citationThe Laryngoscope, 2011; 121(9):2045-2046
dc.identifier.doi10.1002/lary.21882
dc.identifier.issn0023-852X
dc.identifier.issn1531-4995
dc.identifier.orcidForeman, A. [0000-0002-6560-6391]
dc.identifier.orcidWormald, P.J. [0000-0001-7753-7277]
dc.identifier.urihttp://hdl.handle.net/2440/87402
dc.language.isoen
dc.publisherWILEY-BLACKWELL
dc.rights© 2011 The American Laryngological, Rhinological, and Otological Society, Inc.
dc.source.urihttps://doi.org/10.1002/lary.21882
dc.titleIn response to targeted imaging modality selection for bacterial biofilms in chronic rhinosinusitis and different biofilms, different disease? A clinical outcomes study
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications